Health
EU-AstraZeneca vaccine court hearing set for 26 May
The European Union and AstraZeneca will begin their oral arguments on 26 May in the bloc’s legal action against the pharmaceutical giant over coronavirus vaccine shortfalls, a Belgian court said Wednesday.
The EU is suing AstraZeneca for allegedly breaking their purchase agreement by massively under-delivering doses of the COVID-19 jab for its 27 member states.
The British-Swedish company has dismissed the case as “without merit” and insisted it will fight it fiercely in the Belgian courts, which have jurisdiction over the deal.
The legal action — which started Wednesday with a procedural session in a Brussels court — is being expedited to speed up a ruling.
The EU says the case is aimed at ramping up deliveries of the doses it is entitled to and pressing the firm to use plants in Britain mentioned in the contract to supply the bloc.
“The (European) Commission and the member states believe that AstraZeneca has violated many obligations under the pre-order contract, regarding the production as well as the delivery of vaccines,” Rafael Jafferali, a lawyer for the EU, told AFP.
“We will explain this to the court.”
AstraZeneca’s legal counsel Hakim Boularbah said the firm “deeply regrets” the EU’s decision to launch the action.
“We hope to resolve this dispute as soon as possible,” he told journalists.
The row erupted between the European Commission and AstraZeneca after major delivery shortages hampered early efforts to roll out inoculations across the drive.
The EU executive — which is responsible for ordering vaccines for the bloc — says overall the firm is set to deliver only a third of the 300 million doses it has promised by the end of June.
AstraZeneca’s boss has insisted the company only committed to a “best reasonable efforts” clause to meet supply targets, and it says it is on course to deliver almost 50 million doses by the end of this month.
The commission says the contract shows greater legal responsibility and officials have pointed out that the company has largely delivered promised doses to Britain, where it is headquartered.
The EU initially intended to use the AstraZeneca jab as the main workhorse to power the bloc’s inoculation drive — but has now switched focus to the more expensive BioNTech/Pfizer vaccine as its mainstay.
The bloc is hoping an uptick in deliveries of vaccines from Pfizer, Moderna and the single-shot Johnson & Johnson jabs can help it gain ground on inoculation pacesetters like the United States and Britain.
— AFP
Health
Singapore to offer Mpox vaccine to high-risk healthcare workers and close contacts
Singapore will offer free mpox vaccines to high-risk healthcare workers and close contacts of confirmed cases, amid concerns over the deadlier clade 1 strain. The Ministry of Health stated mask-wearing is unnecessary for the public, as the virus primarily spreads through close contact.
Singapore has announced new measures to combat the spread of the deadlier mpox clade 1 strain, as concerns mount over its potential impact.
At a press conference on Wednesday, Health Minister Ong Ye Kung revealed that the mpox vaccine JYNNEOS will be offered to two key groups: healthcare workers at high risk of exposure and close contacts of confirmed cases.
The announcement comes as the World Health Organization (WHO) declared mpox a global public health emergency for the second time in two years due to the resurgence of clade 1 cases in Africa.
Minister Ong emphasized that while there is limited data on the virus, the government has sufficient information to implement precautionary measures. “We do not have full information on the characteristics of this virus, but we have good information on how it behaves,” he said. Ong added that Singapore’s response plan would remain flexible and adapt as the global understanding of the virus evolves.
Response Measures and Border Controls
As part of a whole-of-government approach, the Ministry of Health (MOH) has coordinated a comprehensive public health strategy to prevent the spread of mpox clade 1 in Singapore.
While no direct flights connect Singapore to countries experiencing mpox outbreaks, temperature and visual screening measures have been put in place at Changi and Seletar airports for travellers and crew arriving from affected regions. Screening at sea checkpoints has also been implemented for ships from mpox-affected areas.
Travellers are required to report any mpox-related symptoms (such as fever or rash) and provide travel history via the SG Arrival Card. Those displaying symptoms will be assessed by medical professionals at the borders and referred to hospitals if necessary.
Vaccination Strategy and Quarantine
The JYNNEOS vaccine, previously approved in Singapore for both smallpox and mpox, will be offered to two key groups. Healthcare workers at the National Centre for Infectious Diseases (NCID) and other high-risk facilities will be provided with pre-exposure prophylaxis, in addition to existing infection control protocols. Close contacts of confirmed mpox cases will receive a single vaccine dose within 14 days of exposure during their 21-day quarantine period. The MOH has assured that the current vaccine supply is sufficient to meet the needs of these priority groups.
MOH highlighted that a “significant” portion of the population—those born before 1981—may already have some immunity due to mandatory smallpox vaccinations administered in Singapore until that year.
Detection, Isolation, and Treatment
MOH has instructed all healthcare providers to be vigilant and promptly report any suspected mpox cases, especially those involving clade 1.
Suspected cases will be referred to designated hospitals for further assessment and testing, with paediatric cases directed to KK Women’s and Children’s Hospital and adult-child family groups to National University Hospital. Confirmed clade 1 cases will be isolated in healthcare facilities until they are no longer infectious to prevent further community spread.
Testing for mpox involves polymerase chain reaction (PCR) testing conducted at the National Public Health Laboratory. While there are no rapid point-of-care test kits available, cases are managed through supportive care. For severe cases, antivirals such as Tecovirimat may be used, aligning with treatment protocols in other countries.
Community Measures and Mask-Wearing
Based on current data, the virus spreads mainly through close physical contact, such as within households. Therefore, mask-wearing for the general public is not recommended unless there is significant evidence of respiratory transmission. MOH has stated that if respiratory spread becomes a concern, measures such as mask-wearing on public transport or in crowded indoor spaces may be considered.
In settings such as preschools and schools, existing infectious disease protocols—such as visual screenings for symptoms and hygiene measures—will continue to be implemented to control any potential spread. Additionally, MOH, in collaboration with the Ministry of Manpower and the National Environment Agency, has begun wastewater testing at migrant worker dormitories and the Onboard Centre to detect any presence of mpox.
Ongoing Surveillance and Preparedness
MOH will continue to work closely with international counterparts to monitor the evolving mpox situation. Border measures, detection protocols, and vaccination strategies will be adjusted as needed to safeguard Singapore’s public health.
As of now, Singapore has not detected any clade 1 cases, with all 14 mpox cases this year involving the less severe clade 2 subtype. However, Minister Ong stressed the importance of vigilance, particularly in protecting vulnerable groups such as children and the immunocompromised, should clade 1 reach Singapore.
“Our best course of action is to suppress the spread, provide proper treatment, and have an effective vaccination strategy in place,” Ong said. Despite the concern surrounding mpox, Ong reassured the public that it is unlikely to cause the level of disruption seen during COVID-19.
Health
Baby born with 26 fingers and toes in India, considered reincarnation of Hindu deity
A baby in Bharatpur, India, was born with 26 fingers and toes, believed to be a reincarnation of a Hindu deity.
A baby was born with an astonishing 26 fingers and toes in a hospital in Bharatpur, a city in the northern Indian state of Rajasthan.
While medical experts describe the condition as a genetic anomaly known as polydactyly, the baby’s family is rejoicing, believing that their child is the reincarnation of a revered Hindu deity.
The baby, whose name has not been disclosed, entered the world with 14 fingers on its hands and 12 toes on its feet, leaving medical professionals both astounded and intrigued.
As reported by the Daily Mail on Tuesday (19 Sep), doctors described it as a genetic anomaly known as polydactyly, where someone is born with one or more extra fingers or toes. It can occur on one or both hands or feet.
However, the family is reported to be happy and openly refers to it as a reincarnation of Dholagarh Devi, a famous local deity whose temple is located near the girl’s birthplace. The deity’s statue depicts a young girl with multiple hands.
The baby’s mother, Sarju Devi, aged 25, expressed immense joy at the birth of her child. Sarju Devi’s brother, whose name was not disclosed, spoke to local media, proudly stating, “My sister has given birth to a baby with 26 fingers, and we consider it to be the incarnation of Dholagarh Devi. We are overjoyed.”
The baby’s father, Gopal Bhattacharya, a Central Reserve Police Force officer, is also reported to be ecstatic about the birth.
Dr BS Soni, a medical practitioner at the hospital where the baby was born, offered a medical perspective on the condition, saying, “Having 26 fingers is not harmful, but it is a genetic abnormality. The little girl is perfectly healthy.”
The big question now is whether the family from Bharatpur, in the northern Indian state of Rajasthan, plans to undergo surgery to reduce the number of fingers and toes on their newborn baby.
This decision is yet to be disclosed as the family continues to bask in the belief that their child is a divine reincarnation.
-
Singapore3 days ago
Minister K Shanmugam transfers Astrid Hill GCB to UBS Trustees for S$88 Million following Ridout Road controversy
-
Singapore1 week ago
Singapore woman’s suicide amidst legal battle raises concerns over legal system
-
Parliament5 days ago
Minister Shanmugam rejects request for detailed information on visa-free visitor offences: Cites bilateral considerations
-
Diplomacy1 week ago
India PM Narendra Modi meets with PM Lawrence Wong; Four MoUs signed
-
Opinion2 weeks ago
Singaporean voters and the ‘Battered Wife Syndrome’
-
Parliament6 days ago
PAP MPs attack WP Gerald Giam in Parliament over NTUC independence from ruling party
-
Politics1 week ago
PAP adopts SDP policies after criticizing them: Dr Chee urges Singaporeans to see through tactics
-
Politics4 days ago
11 former or current PAP MPs & Ministers underscore heavy presence in NTUC leadership